| Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems H Dianat-Moghadam, M Heidarifard, R Jahanban-Esfahlan, Y Panahi, ... Journal of controlled release 288, 62-83, 2018 | 138 | 2018 |
| An update of Nrf2 activators and inhibitors in cancer prevention/promotion F Pouremamali, A Pouremamali, M Dadashpour, N Soozangar, F Jeddi Cell Communication and Signaling 20 (1), 100, 2022 | 113 | 2022 |
| An evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin S Bastani, V Vahedian, M Rashidi, A Mir, S Mirzaei, I Alipourfard, ... Biomedicine & Pharmacotherapy 153, 113297, 2022 | 65 | 2022 |
| Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment NF Maroufi, V Vahedian, S Hemati, MR Rashidi, M Akbarzadeh, M Zahedi, ... Pathology-Research and Practice 216 (5), 152919, 2020 | 64 | 2020 |
| The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated … NF Maroufi, V Vahedian, M Akbarzadeh, M Mohammadian, M Zahedi, ... Breast Cancer 27, 613-620, 2020 | 58 | 2020 |
| Graphene oxide: a promising material for regenerative medicine and tissue engineering M Maleki, R Zarezadeh, M Nouri, AR Sadigh, F Pouremamali, Z Asemi, ... Biomolecular Concepts 11 (1), 182-200, 2020 | 52 | 2020 |
| Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance Z Payandeh, AP Tazehkand, G Barati, F Pouremamali, H Kahroba, ... Biochimie 179, 32-45, 2020 | 45 | 2020 |
| The MicroRNA‐326: Autoimmune diseases, diagnostic biomarker, and therapeutic target G Jadideslam, K Ansarin, E Sakhinia, S Alipour, F Pouremamali, ... Journal of cellular physiology 233 (12), 9209-9222, 2018 | 39 | 2018 |
| Potential therapeutic effects of melatonin mediate via miRNAs in cancer P Pourmohammad, NF Maroufi, M Rashidi, V Vahedian, F Pouremamali, ... Biochemical Genetics, 1-23, 2022 | 26 | 2022 |
| The role of SOX family in cancer stem cell maintenance: With a focus on SOX2 F Pouremamali, V Vahedian, N Hassani, S Mirzaei, A Pouremamali, ... Pathology-Research and Practice 231, 153783, 2022 | 24 | 2022 |
| Nrf2-ME-1 axis is associated with 5-FU resistance in gastric cancer cell line F Pouremamali, F Jeddi, N Samadi Process Biochemistry 114, 174-184, 2022 | 11 | 2022 |
| Reduced levels of miR–28 and miR–200a act as predictor biomarkers of aggressive clinicopathological characteristics in gastric cancer patients F Jeddi, S Alipour, N Najafzadeh, M Dadashpour, F Pouremamali, ... Galen Medical Journal 8, e1329, 2019 | 11 | 2019 |
| Epigenetics and Behçet’s disease: DNA methylation specially highlighted J Farhadi, M Nouri, E Sakhinia, N Samadi, Z Babaloo, S Alipour, ... Iranian Journal of Allergy, Asthma and Immunology, 462-472, 2019 | 9 | 2019 |
| Corrigendum to" Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems".[Journal of Controlled Release 288 (2018) 62-83] H Dianat-Moghadam, M Heidarifard, R Jahanban-Esfahlan, Y Panahi, ... Journal of controlled release: official journal of the Controlled Release …, 2019 | 3 | 2019 |
| The potential therapeutic effect of melatonin in oxaliplatin combination therapy against chemoresistant colorectal cancer cells M Dehghanzad, M Mohammadi, M Nejati, F Pouremamali, NF Maroufi, ... Molecular Biology Reports 51 (1), 348, 2024 | 2 | 2024 |
| Balancing Nrf2 activation: A promising strategy for cancer treatment F Pouremamali, A Pouremamali, M Dadashpour, N Soozangar, F Jeddi | | 2023 |
| Surveillance and epidemiology of hepatitis B, C, D and G in Khuzestan Province, Southwest Iran-A review A Pouremamali, F Pouremamali | | |
